{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T11:15:35Z","timestamp":1782472535756,"version":"3.54.5"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.bcp.2025.116739","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T16:19:38Z","timestamp":1736007578000},"page":"116739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Runcaciguat activates soluble guanylyl cyclase via the histidine essential for heme binding and nitric oxide activation"],"prefix":"10.1016","volume":"232","author":[{"given":"Theresa","family":"Wittrien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"R\u00fchle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christin","family":"Elgert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilka","family":"Mathar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Sandner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6nke","family":"Behrends","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.bcp.2025.116739_b0005","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1021\/bi00184a036","article-title":"Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states","volume":"33","author":"Stone","year":"1994","journal-title":"Biochemistry"},{"issue":"38","key":"10.1016\/j.bcp.2025.116739_b0010","doi-asserted-by":"crossref","first-page":"27836","DOI":"10.1074\/jbc.M601078200","article-title":"Ligand selectivity of soluble guanylyl cyclase: effect of the hydrogen-bonding tyrosine in the distal heme pocket on binding of oxygen, nitric oxide, and carbon monoxide","volume":"281","author":"Martin","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.bcp.2025.116739_b0015","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1073\/pnas.91.7.2592","article-title":"Mutation of His-105 in the beta 1 subunit yields a nitric oxide-insensitive form of soluble guanylyl cyclase","volume":"91","author":"Wedel","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"26","key":"10.1016\/j.bcp.2025.116739_b0020","doi-asserted-by":"crossref","first-page":"14753","DOI":"10.1073\/pnas.96.26.14753","article-title":"A molecular basis for nitric oxide sensing by soluble guanylate cyclase","volume":"96","author":"Zhao","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2025.116739_b0245","doi-asserted-by":"crossref","unstructured":"Chen L, Liu R. Structure of human soluble guanylate cyclase in the inactive state at 3.1 angstrom. 2023. 10.2210\/pdb8HBE\/pdb.","DOI":"10.2210\/pdb8hbe\/pdb"},{"key":"10.1016\/j.bcp.2025.116739_b0250","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.niox.2023.03.002","article-title":"NO binds to the distal site of haem in the fully activated soluble guanylate cyclase","volume":"134\u2013135","author":"Liu","year":"2023","journal-title":"Nitric Oxide."},{"issue":"W1","key":"10.1016\/j.bcp.2025.116739_b0255","doi-asserted-by":"crossref","first-page":"W431","DOI":"10.1093\/nar\/gkab314","article-title":"Mol* Viewer: modern web app for 3D visualization and analysis of large biomolecular structures","volume":"49","author":"Sehnal","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.116739_b0260","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"issue":"2890","key":"10.1016\/j.bcp.2025.116739_b0025","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0140-6736(02)46032-1","article-title":"Nitro-glycerine as a remedy for angina pectoris","volume":"113","author":"Murrell","year":"1879","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.bcp.2025.116739_b0030","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.2146\/ajhp130777","article-title":"Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension","volume":"71","author":"Bishop","year":"2014","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"5","key":"10.1016\/j.bcp.2025.116739_b0035","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1177\/10600280211041384","article-title":"Vericiguat: a novel oral soluble guanylate cyclase stimulator for the treatment of heart failure","volume":"56","author":"Campbell","year":"2022","journal-title":"Ann. Pharmacother."},{"issue":"9","key":"10.1016\/j.bcp.2025.116739_b0040","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrd2038","article-title":"NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential","volume":"5","author":"Evgenov","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2025.116739_b0045","first-page":"20","article-title":"Soluble guanylate cyclase stimulators and their potential use: a patent review","volume":"1","author":"Sandner","year":"2021","journal-title":"Expert. Opin. Ther. Pat."},{"issue":"9","key":"10.1016\/j.bcp.2025.116739_b0050","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1172\/JCI28371","article-title":"Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels","volume":"116","author":"Stasch","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"26","key":"10.1016\/j.bcp.2025.116739_b0055","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1021\/bi200794c","article-title":"Oxidation and loss of heme in soluble guanylyl cyclase from Manduca sexta","volume":"50","author":"Fritz","year":"2011","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.bcp.2025.116739_b0060","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0026-895X(25)10233-2","article-title":"Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-1,2,4oxadiazolo4,3-aquinoxalin-1-one","volume":"48","author":"Garthwaite","year":"1995","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2025.116739_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0026-895X(25)09113-8","article-title":"Characterization of 1H-1,2,4oxadiazolo4,3-aquinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase","volume":"50","author":"Schrammel","year":"1996","journal-title":"Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2025.116739_b0070","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1476-5381.2009.00263.x","article-title":"Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation","volume":"157","author":"Hoffmann","year":"2009","journal-title":"Br. J. Pharmacol.."},{"key":"10.1016\/j.bcp.2025.116739_b0075","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.crstbi.2021.11.003","article-title":"Replacement of heme by soluble guanylate cyclase (sGC) activators abolishes heme-nitric oxide\/oxygen (H-NOX) domain structural plasticity","volume":"3","author":"Argyriou","year":"2021","journal-title":"Curr. Res. Struct. Biol."},{"key":"10.1016\/j.bcp.2025.116739_b0080","article-title":"Soluble GC stimulators and activators: Past, present and future","author":"Sandner","year":"2021","journal-title":"Br. J. Pharmacol.."},{"issue":"13","key":"10.1016\/j.bcp.2025.116739_b0085","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1021\/bi972686m","article-title":"Identification of histidine 105 in the beta1 subunit of soluble guanylate cyclase as the heme proximal ligand","volume":"37","author":"Zhao","year":"1998","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.bcp.2025.116739_b0090","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1074\/jbc.M310141200","article-title":"Identification of residues crucially involved in the binding of the heme moiety of soluble guanylate cyclase","volume":"279","author":"Schmidt","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.116739_b0095","doi-asserted-by":"crossref","first-page":"8482","DOI":"10.1038\/ncomms9482","article-title":"Cardiovascular and pharmacological implications of haem-deficient NO-unresponsive soluble guanylate cyclase knock-in mice","volume":"6","author":"Thoonen","year":"2015","journal-title":"Nat. Commun."},{"issue":"33","key":"10.1016\/j.bcp.2025.116739_b0100","doi-asserted-by":"crossref","first-page":"30737","DOI":"10.1074\/jbc.M102549200","article-title":"Nitric oxide activates the beta 2 subunit of soluble guanylyl cyclase in the absence of a second subunit","volume":"276","author":"Koglin","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.116739_b0105","unstructured":"G. Schultz, E.G. B\u00f6hme, E. Guanylate cyclase. GTPpyrophosphatelyase (cyclizing) EC 4.6.1.2. Method of Enzymatic Analysis. 1984;(3rd Ed.):379-389."},{"issue":"5","key":"10.1016\/j.bcp.2025.116739_b0110","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1152\/jappl.2000.88.5.1537","article-title":"A new method for measurement of blood pressure, heart rate, and activity in the mouse by radiotelemetry","volume":"88","author":"Mills","year":"2000","journal-title":"J. Appl. Physiol. (1985)"},{"issue":"11","key":"10.1016\/j.bcp.2025.116739_b0115","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1111\/bph.15586","article-title":"Novel soluble guanylyl cyclase activators increase glomerular cGMP, induce vasodilation and improve blood flow in the murine kidney","volume":"179","author":"Stehle","year":"2022","journal-title":"Br. J. Pharmacol.."},{"key":"10.1016\/j.bcp.2025.116739_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1220095","article-title":"Ameliorating diabetes-associated atherosclerosis and diabetic nephropathy through modulation of soluble guanylate cyclase","volume":"10","author":"Sharma","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"issue":"29","key":"10.1016\/j.bcp.2025.116739_b0125","doi-asserted-by":"crossref","first-page":"22651","DOI":"10.1074\/jbc.M110.111559","article-title":"Structure of cinaciguat (BAY 58-2667) bound to Nostoc H-NOX domain reveals insights into heme-mimetic activation of the soluble guanylyl cyclase","volume":"285","author":"Martin","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.bcp.2025.116739_b0130","doi-asserted-by":"crossref","first-page":"8948","DOI":"10.1021\/jm400539d","article-title":"Insights into soluble guanylyl cyclase activation derived from improved heme-mimetics","volume":"56","author":"MvW","year":"2013","journal-title":"J. Med. Chem."},{"issue":"20","key":"10.1016\/j.bcp.2025.116739_b0135","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1021\/bi301657w","article-title":"Insights into BAY 60-2770 activation and S-nitrosylation-dependent desensitization of soluble guanylyl cyclase via crystal structures of homologous nostoc H-NOX domain complexes","volume":"52","author":"Kumar","year":"2013","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.bcp.2025.116739_b0140","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.1038\/s41467-021-25617-0","article-title":"Activation mechanism of human soluble guanylate cyclase by stimulators and activators","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.116739_b0145","doi-asserted-by":"crossref","unstructured":"Wittrien, Theresa; Elgert, Christin; R\u00fchle, Anne; Sandner, Peter; Behrends, S\u00f6nke (2022): Tyrosine 112 in the sGC \u03b21 subunit: activity enhancer for BAY60\u20112770 (Poster). 10th International Conference on cGMP, Augsburg, Deutschland. Meeting abstracts from the 10th international conference on cGMP: generators, effectors and therapeutic implications. J. Transl. Med. 2023;21(Suppl 1):35. https:\/\/doi.org\/10.1186\/s12967-022-03800-1.","DOI":"10.1186\/s12967-022-03800-1"},{"issue":"2","key":"10.1016\/j.bcp.2025.116739_b0150","first-page":"71","article-title":"Nitric oxide-independent activation of soluble guanylate cyclase by BAY 60-2770 in experimental liver fibrosis","volume":"58","author":"Knorr","year":"2008","journal-title":"Arzneimittelforschung"},{"issue":"3","key":"10.1016\/j.bcp.2025.116739_b0155","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1124\/jpet.115.230706","article-title":"A soluble guanylate cyclase activator inhibits the progression of diabetic nephropathy in the ZSF1 Rat","volume":"356","author":"Boustany-Kari","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"9","key":"10.1016\/j.bcp.2025.116739_b0160","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/2211-5463.12103","article-title":"Differential heme release from various hemoglobin redox states and the upregulation of cellular heme oxygenase-1","volume":"6","author":"Kassa","year":"2016","journal-title":"FEBS Open Bio."},{"issue":"5","key":"10.1016\/j.bcp.2025.116739_b0165","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.bbapap.2016.02.012","article-title":"The molecular mechanism of heme loss from oxidized soluble guanylate cyclase induced by conformational change","volume":"1864","author":"Pan","year":"2016","journal-title":"Biochim. Biophys. Acta."},{"issue":"2","key":"10.1016\/j.bcp.2025.116739_b0170","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1432-1033.1996.0380h.x","article-title":"A functional heme-binding site of soluble guanylyl cyclase requires intact N-termini of alpha 1 and beta 1 subunits","volume":"240","author":"Foerster","year":"1996","journal-title":"Eur. J. Biochem."},{"issue":"24","key":"10.1016\/j.bcp.2025.116739_b0175","doi-asserted-by":"crossref","first-page":"6863","DOI":"10.1002\/j.1460-2075.1996.tb01078.x","article-title":"Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme","volume":"15","author":"Friebe","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2025.116739_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173203","article-title":"Tyrosine 135 of the \u03b21 subunit as binding site of BAY-543: Importance of the Y-x-S-x-R motif for binding and activation by sGC activator drugs","volume":"881","author":"R\u00fchle","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2025.116739_b0185","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bcp.2019.02.007","article-title":"A novel soluble guanylyl cyclase activator, BR 11257, acts as a non-stabilising partial agonist of sGC","volume":"163","author":"Elgert","year":"2019","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2025.116739_b0190","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/sj.emboj.7601521","article-title":"NO and CO differentially activate soluble guanylyl cyclase via a heme pivot-bend mechanism","volume":"26","author":"Ma","year":"2007","journal-title":"EMBO J."},{"issue":"47","key":"10.1016\/j.bcp.2025.116739_b0195","doi-asserted-by":"crossref","first-page":"19753","DOI":"10.1073\/pnas.0911645106","article-title":"A structural basis for H-NOX signaling in Shewanella oneidensis by trapping a histidine kinase inhibitory conformation","volume":"106","author":"Erbil","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"issue":"40","key":"10.1016\/j.bcp.2025.116739_b0200","doi-asserted-by":"crossref","first-page":"E4156","DOI":"10.1073\/pnas.1416936111","article-title":"Structural insights into the role of iron-histidine bond cleavage in nitric oxide-induced activation of H-NOX gas sensor proteins","volume":"111","author":"Herzik","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"issue":"2","key":"10.1016\/j.bcp.2025.116739_b0205","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1124\/mol.117.109918","article-title":"Irreversible activation and stabilization of soluble guanylate cyclase by the protoporphyrin IX mimetic cinaciguat","volume":"93","author":"Kollau","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2025.116739_b0210","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bcp.2017.11.010","article-title":"BAY 60-2770 activates two isoforms of nitric oxide sensitive guanylyl cyclase: evidence for stable insertion of activator drugs","volume":"147","author":"S\u00f6mmer","year":"2018","journal-title":"Biochem Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2025.116739_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e11438","article-title":"Design, synthesis and biological evaluation of new 3,4-dihydroquinoxalin-2(1H)-one derivatives as soluble guanylyl cyclase (sGC) activators","volume":"8","author":"Kintos","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.bcp.2025.116739_b0220","doi-asserted-by":"crossref","DOI":"10.1124\/molpharm.122.000624","article-title":"BAY58-2667 activates different sGC species by distinct mechanisms that indicate its principal target in cells is the heme-free sGC\u03b2-Hsp90 complex","author":"Dai","year":"2023","journal-title":"Mol. Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2025.116739_b0225","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/sj.bjp.0707687","article-title":"Probing the presence of the ligand-binding haem in cellular nitric oxide receptors","volume":"153","author":"Roy","year":"2008","journal-title":"Br. J. Pharmacol.."},{"issue":"21","key":"10.1016\/j.bcp.2025.116739_b0230","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1161\/CIRCULATIONAHA.108.800292","article-title":"Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure","volume":"119","author":"Lapp","year":"2009","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.bcp.2025.116739_b0235","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/eurjhf\/hfs093","article-title":"Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes","volume":"14","author":"Gheorghiade","year":"2012","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.bcp.2025.116739_b0240","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.0000000000000418","article-title":"Effect of avenciguat on albuminuria in patients with CKD: two randomized placebo-controlled trials","author":"Heerspink","year":"2024","journal-title":"J Am Soc Nephrol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225000012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225000012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T05:12:54Z","timestamp":1738818774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225000012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":52,"alternative-id":["S0006295225000012"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.116739","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Runcaciguat activates soluble guanylyl cyclase via the histidine essential for heme binding and nitric oxide activation","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.116739","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116739"}}